HAILEY RAY: Open Payments
NPI 1598350423 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,560 in 76 payments from 30 companies in 2025. Trend: 2023 $1,058 · 2024 $2,672 · 2025 $2,560
Food & beverage: $1,560Long term medical supply or device loan: $1,000
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $1,191 |
| Janssen Biotech, Inc. | 5 | $236 |
| Gilead Sciences, Inc. | 7 | $156 |
| Caris MPI, Inc. | 3 | $113 |
| AstraZeneca Pharmaceuticals LP | 4 | $91 |
| E.R. Squibb & Sons, L.L.C. | 4 | $86 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| TAIHO ONCOLOGY, INC. | 2 | $53 |
| SERVIER PHARMACEUTICALS LLC | 3 | $52 |
| Lilly USA, LLC | 2 | $49 |
Products named: KISQALI, RYBREVANT, Trodelvy, MI CANCER SEEK, TALVEY, OPDIVO, LIBTAYO, LONSURF.
Industry payments across TN — which companies pay providers there.
